DPP4 and Hypoglycemia: However, the risk of hypoglycemia varies among different oral medications; for example, sulfonylureas and meglitinides are associated with a higher risk of hypoglycemia, whereas agents like metformin, DPP-4 inhibitors, and SGLT-2 inhibitors have a lower hypoglycemic risk.